Corient Private Wealth’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-19,329
Closed -$251K 2466
2025
Q1
$251K Buy
19,329
+473
+3% +$6.26K ﹤0.01% 1948
2024
Q4
$241K Buy
18,856
+643
+4% +$7.78K ﹤0.01% 2013
2024
Q3
$203K Buy
18,213
+1,931
+12% +$21.3K ﹤0.01% 2219
2024
Q2
$183K Buy
+16,282
New +$190K ﹤0.01% 2135

Other funds holding DVAX

Corient Private Wealth's DVAX Position: Q2 2025 in Review

Corient Private Wealth sold out of Dynavax Technologies (DVAX) in Q2 2025, closing a stake of 19,329 shares — an estimated $251K sold.

Corient Private Wealth first reported a position in DVAX in Q2 2024 and held it in 4 quarters. The position peaked at $251K in Q1 2025. 268 funds tracked by Wall St. Rank hold DVAX as of Q2 2025.

  • Corient Private Wealth reported no remaining Dynavax Technologies position as of Q2 2025 after selling out during the quarter.
  • Corient Private Wealth sold 19,329 Dynavax Technologies shares in Q2 2025, an estimated $251K.
  • Corient Private Wealth first reported a position in Dynavax Technologies in Q2 2024 and held it in 4 quarters.
  • Corient Private Wealth's Dynavax Technologies position peaked at $251K in Q1 2025.
  • 268 funds tracked by Wall St. Rank held Dynavax Technologies as of Q2 2025.

Based on Corient Private Wealth's 13F filing for Q2 2025, filed 15 Aug 2025.